Lifetime Achievement Award, lecanemab and biomarkers in focus at CTAD ...Middle East

STOCKHOLM, Oct. 24, 2024 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) founder Lars Lannfelt will be presented with the Lifetime Achievement Award in Alzheimer's Disease Therapeutic Research at the Clinical Trials for Alzheimer's Disease Conference (CTAD) held in...

Hence then, the article about lifetime achievement award lecanemab and biomarkers in focus at ctad was published today ( Thursday 24/10/2024 - 09:16 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Lifetime Achievement Award, lecanemab and biomarkers in focus at CTAD )

Also on site :

• The White Sox Have Decisions To Make With Munetaka Murakami
• Anthropic says engineering missteps were behind Claude Code’s monthlong decline after weeks of user backlash
• Largest catch-up initiative delivers over 100 million childhood vaccinations